News
The program known as PEPFAR is one of the most effective and popular U.S. foreign aid projects in history, and the government ...
1d
AllAfrica on MSNMomentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To ActionNew WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
Even with the HIV prevention waters now dominated by Gilead Science’s Yeztugo (lenacapavir), Merck & Co. is not afraid to swim deeper in. | Even with the HIV prevention waters now dominated by Gilead ...
Ending USAID could lead to the deaths of 14 million people over the next five years, an analysis from a medical journal predicts.
U.S. funded treatments in the country have helped reduce deaths from HIV/AIDS to around 14,000 a year, from as high as ...
Breeze, a Louisville nonprofit that supports LGBTQ+ young adults, paused its free HIV testing services due to federal funding ...
BOISE, Idaho (AP) — An Idaho doctor and four residents are challenging a new state law that halts some of the few public benefits available to people living in the U.S. unlawfully, including a program ...
A newly approved HIV medication provides near-total protection against infection with just two injections a year. It's called Lenacapavir. But the high price of the drug could limit its reach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results